Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Reckitt Benckiser Healthcare (UK) Ltd
Freepost, RSBU-TEBT-GSTU, Reckitt Benckiser, Kingston Upon Thames, KT2 6LZ, UK
Telephone: +44 (0)500 455 456
WWW: http://www.reckittbenckiser.com
Medical Information Direct Line: +44 (0)500 455 456
Customer Care direct line: +44 (0)500 455 456

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 10/10/2011
SPC Lanacane Creme


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Lanacane Creme


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active Ingredient

%

Specification

Benzocaine

3.0

E.P.


Go to top of the page
3. PHARMACEUTICAL FORM

Emulsion creme in an aluminium tube.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For symptomatic relief of minor pain, itching, and irritation in the following localised skin conditions, such as insect bites, nettle stings, minor skin abrasions, and external genital and external anal itching.


Go to top of the page
4.2 Posology and method of administration

For topical administration.

Adults and children aged twelve years and above:

Apply to the affected area. Repeat as needed three times daily.


Go to top of the page
4.3 Contraindications

Known sensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

Not for use on extensive body area or on the eyes. If symptoms persist more than one week, discontinue use and consult a doctor.

For external use only.

Not suitable for children under twelve years of age.

Keep out of the reach of children.

Do not use during pregnancy without first consulting a doctor.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Do not use in pregnancy without first consulting a doctor.


Go to top of the page
4.7 Effects on ability to drive and use machines

None.


Go to top of the page
4.8 Undesirable effects

May possibly cause sensitivity. If this occurs, treatment should be stopped and medical advice sought.


Go to top of the page
4.9 Overdose

None.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Benzocaine applied to the skin acts as a topical local anaesthetic, acting on nerve endings and receptors, temporarily reducing the itching and minor pain associated with various thermal, mechanical or chemical stimuli. The vanishing creme base also helps soothe, lubricate, and protect irritated skin.


Go to top of the page
5.2 Pharmacokinetic properties

When used as directed, some benzocaine applied topically may be absorbed, but this should be of negligible consequence. Benzocaine has the quickest onset and shortest duration of action of the commonly used topical anaesthetics.


Go to top of the page
5.3 Preclinical safety data

None


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Chlorothymol, diethylene glycol monoethyl ether, docusate sodium, fragrance, glycerine, glycerol monostearate, isopropyl alcohol, stearic acid, sulfonated castor oil, triethanolamine, water, zinc oxide.


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

Five years.


Go to top of the page
6.4 Special precautions for storage

Store at room temperature (below 30°C).


Go to top of the page
6.5 Nature and contents of container

In 30 gram and 60 gram aluminium tubes with a membrane covered nozzle and white high density polyethylene cap, overpacked in a printed folding cardboard unit carton


Go to top of the page
6.6 Special precautions for disposal and other handling

None


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Reckitt Benckiser Healthcare (UK) Ltd

Slough

SL1 4AQ


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00063/0671


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

26th April 1990 / 23rd July 1996


Go to top of the page
10. DATE OF REVISION OF THE TEXT

26/07/2011



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/24251/SPC/


Active Ingredients/Generics

 
  benzocaine